Actuate Therapeutics IncACTUNASDAQ
Loading
Year-over-year research & development expense growth
Latest
-13.97%
↓ 326% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineDecelerating
Average
6.17%
Historical baseline
| Period | Value |
|---|---|
| 2024 | -13.97% |
| 2023 | 32.47% |
| 2022 | 0.00% |